"SALT Trial" Study of Ascending Levels of Tolvaptan in Hyponatremia
Status:
Completed
Trial end date:
2006-02-01
Target enrollment:
Participant gender:
Summary
This study's purpose is to determine whether tolvaptan can safely and effectively return the
body's balance of sodium and water toward normal, and to characterize and quantify the
potential clinical benefits of this treatment.
Phase:
Phase 3
Details
Lead Sponsor:
Otsuka Pharmaceutical Development & Commercialization, Inc.